David V Daniels, MD
Interventional Cardiology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center · California Pacific Medical Center- Van Ness Campus · Mills-Peninsula Medical Center · Sutter Lakeside Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Daniels’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A96709 · Current
Licensed to practise in California · since 2006 · expires 2027-10-31 · Loyola University of Chicago Stritch School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sutter Lakeside HospitalLakeport, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sutter Lakeside Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.7 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 379 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 31 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.249 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -25.4 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -37.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.3) · 564 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (209 patients answered, 18% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$257,928
Medicare paid this office $257,928 for 272 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of aortic valve through the skin and femoral artery | 92 | $56,402 | $613 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $19,827 | $154 |
| Long return visit (40+ min) | 83 | $18,394 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $18,015 | $105 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 30 | $16,428 | $342 |
See all 16 services
| Replacement of aortic valve through the skin and femoral artery | 92 | $56,402 | $613 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $19,827 | $154 |
| Long return visit (40+ min) | 83 | $18,394 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $18,015 | $105 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 30 | $16,428 | $342 |
| New patient visit (60+ min) | 77 | $15,096 | $196 |
| Critical care, first 30-74 minutes | 34 | $14,899 | $184 |
| Balloon dilation repair of aortic valve | 11 | $12,020 | $1,093 |
| Repair of congenital abnormality in wall between upper heart chambers with implant | 12 | $8,920 | $743 |
| Insertion of artificial valve between left heart chambers, accessed through the skin | 13 | $8,647 | $665 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 64 | $8,343 | $130 |
| Return visit (30+ min) | 35 | $4,424 | $120 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,113 | $239 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 17 | $1,970 | $116 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 23 | $1,867 | $78 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 11 | $1,054 | $62 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 77 | More than 92% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
272 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 20% · Women 40% · Also on Medicaid 24% · Health risk score 2.09. Above the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Heart failure 75% · Atrial fibrillation 51% · Chronic kidney disease 49% · Diabetes 40% · COPD 26% · Depression 21% · Cancer 18% · Stroke 18% · Dementia 9%.
The office billed $1,623,666, Medicare allowed $323,808 and paid $257,928; for 1,086 services of 69 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 272 | 1,086 | 77 | 2.09 | $1,623,666 | $257,928 |
| 2023 | 298 | 1,086 | 77 | 2.12 | $1,309,572 | $264,207 |
| 2022 | 300 | 1,129 | 78 | 2.10 | $1,191,727 | $256,550 |
| 2021 | 314 | 1,193 | 77 | 2.10 | $1,217,175 | $280,861 |
| 2020 | 344 | 1,357 | 77 | 2.12 | $1,389,827 | $319,370 |
| 2019 | 361 | 1,166 | 77 | 2.14 | $1,149,671 | $295,832 |
| 2018 | 325 | 859 | 79 | 2.10 | $926,441 | $243,347 |
| 2017 | 360 | 984 | 79 | 2.04 | $838,243 | $228,142 |
| 2016 | 328 | 1,019 | 79 | 1.70 | $760,986 | $221,583 |
| 2015 | 660 | 1,276 | 77 | 1.29 | $679,857 | $196,171 |
| 2014 | 729 | 1,327 | 77 | 1.22 | $568,637 | $160,633 |
| 2013 | 379 | 979 | 77 | 1.40 | $435,130 | $124,625 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Replacement of aortic valve through the skin and femoral artery | 87 | $55,550 | $631 |
| Repair of mitral valve through the skin, initial prosthesis | 25 | $29,574 | $1,183 |
| New patient visit (60+ min) | 107 | $20,890 | $195 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $18,314 | $155 |
| Long return visit (40+ min) | 85 | $17,869 | $161 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $15,447 | $359 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $14,005 | $108 |
| Critical care, first 30-74 minutes | 45 | $11,702 | $189 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 62 | $8,801 | $138 |
| Return visit (30+ min) | 43 | $5,708 | $119 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,798 | $292 |
| Repair of mitral valve through the skin, additional prosthesis | 13 | $3,676 | $283 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 19 | $2,723 | $124 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 18 | $1,433 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $492 | $14 |
2022: 17 services
| Replacement of aortic valve through the skin and femoral artery | 82 | $52,270 | $637 |
| New patient visit (60+ min) | 113 | $22,784 | $200 |
| Long return visit (40+ min) | 86 | $22,664 | $161 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 104 | $20,232 | $177 |
| Repair of mitral valve through the skin, initial prosthesis | 16 | $19,009 | $1,188 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $15,934 | $325 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $11,665 | $92 |
| Critical care, first 30-74 minutes | 38 | $11,525 | $192 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 54 | $7,822 | $145 |
| Insertion of artificial valve between left heart chambers, accessed through the skin | 11 | $7,748 | $704 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $3,997 | $250 |
| Return visit (30+ min) | 30 | $3,571 | $108 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 21 | $1,700 | $81 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $1,440 | $120 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 55 | $933 | $14 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 12 | $837 | $64 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $734 | $61 |
2021: 19 services
| Replacement of aortic valve through the skin and femoral artery | 87 | $56,423 | $649 |
| New patient visit (60+ min) | 137 | $27,085 | $198 |
| Long return visit (40+ min) | 99 | $22,504 | $161 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 108 | $20,353 | $180 |
| Insertion of artificial valve between left heart chambers, accessed through the skin | 25 | $19,398 | $776 |
| Repair of mitral valve through the skin, initial prosthesis | 18 | $18,712 | $1,040 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 33 | $16,260 | $346 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 92 | $12,466 | $93 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 64 | $9,327 | $146 |
| Critical care, first 30-74 minutes | 26 | $8,862 | $193 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $4,459 | $279 |
| Return visit (30+ min) | 31 | $3,594 | $106 |
| Repair of mitral valve through the skin, additional prosthesis | 11 | $2,504 | $228 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $2,030 | $135 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 21 | $1,691 | $81 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,287 | $107 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 18 | $1,107 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 56 | $936 | $14 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 13 | $894 | $64 |
2020: 21 services
| Replacement of aortic valve through the skin and femoral artery | 117 | $76,363 | $653 |
| Repair of mitral valve through the skin, initial prosthesis | 27 | $29,613 | $1,021 |
| New patient visit (60+ min) | 149 | $27,625 | $185 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 42 | $19,593 | $356 |
| Long return visit (40+ min) | 88 | $15,511 | $130 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $13,935 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $11,931 | $94 |
| Insertion of artificial valve between left heart chambers, accessed through the skin | 15 | $11,151 | $743 |
| Critical care, first 30-74 minutes | 40 | $8,910 | $194 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 59 | $8,897 | $151 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 23 | $6,382 | $277 |
| Return visit (30+ min) | 51 | $5,881 | $98 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 33 | $4,207 | $120 |
| Balloon dilation of single coronary artery or branch | 12 | $4,090 | $315 |
| Repair of mitral valve through the skin, additional prosthesis | 14 | $3,636 | $242 |
| Telephone medical discussion with physician, 21-30 minutes | 28 | $3,070 | $96 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 36 | $2,955 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 80 | $1,471 | $16 |
| Insertion of tube in right heart chambers for measurement | 12 | $1,334 | $103 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,209 | $93 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 17 | $1,175 | $65 |
2019: 17 services
| Replacement of aortic valve through the skin and femoral artery | 109 | $80,676 | $727 |
| New patient visit (60+ min) | 146 | $27,119 | $186 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 38 | $21,389 | $363 |
| Critical care, first 30-74 minutes | 74 | $18,841 | $190 |
| Balloon dilation repair of aortic valve | 15 | $17,248 | $1,150 |
| Long return visit (40+ min) | 69 | $11,091 | $135 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 54 | $9,415 | $171 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 15 | $8,559 | $571 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $6,647 | $94 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 48 | $6,303 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,235 | $181 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $4,719 | $278 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 44 | $3,713 | $83 |
| Return visit (30+ min) | 32 | $3,320 | $101 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 20 | $1,437 | $65 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $950 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 52 | $868 | $16 |
2018: 16 services
| Replacement of aortic valve through the skin and femoral artery | 137 | $99,983 | $719 |
| New patient visit (60+ min) | 121 | $21,989 | $182 |
| Repair of mitral valve through the skin, initial prosthesis | 18 | $20,041 | $1,055 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $14,328 | $333 |
| Critical care, first 30-74 minutes | 42 | $8,745 | $182 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 13 | $7,433 | $531 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 49 | $6,820 | $136 |
| Long return visit (40+ min) | 43 | $6,655 | $133 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 30 | $5,106 | $170 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,141 | $180 |
| Repair of mitral valve through the skin, additional prosthesis | 13 | $3,589 | $276 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,038 | $89 |
| Return visit (30+ min) | 22 | $2,031 | $92 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 20 | $1,639 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 64 | $1,047 | $15 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $902 | $82 |
2017: 19 services
| Replacement of aortic valve through the skin and femoral artery | 119 | $86,043 | $723 |
| New patient visit (60+ min) | 101 | $18,564 | $184 |
| Critical care, first 30-74 minutes | 55 | $14,055 | $195 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $11,077 | $346 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 54 | $10,352 | $188 |
| Long return visit (40+ min) | 61 | $9,287 | $133 |
| Return visit (30+ min) | 64 | $8,094 | $93 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 11 | $6,535 | $545 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 40 | $5,297 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,607 | $180 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $2,904 | $223 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,139 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 36 | $2,043 | $57 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 11 | $1,813 | $165 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 20 | $1,645 | $82 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $988 | $82 |
| Short return visit (20+ min) | 12 | $922 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 49 | $800 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $35 | $3 |
2016: 18 services
| Replacement of aortic valve through the skin and femoral artery | 87 | $63,067 | $717 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $18,626 | $396 |
| Critical care, first 30-74 minutes | 68 | $17,965 | $195 |
| New patient visit (60+ min) | 97 | $17,892 | $184 |
| Long return visit (40+ min) | 83 | $15,307 | $133 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 63 | $9,500 | $148 |
| Return visit (30+ min) | 69 | $8,217 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $4,725 | $89 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,560 | $207 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,329 | $180 |
| Transitional care management services for problem of high complexity | 19 | $4,190 | $221 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $3,534 | $321 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 15 | $3,043 | $190 |
| Transitional care management services for problem of at least moderate complexity | 18 | $2,828 | $157 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 37 | $2,234 | $57 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,152 | $82 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $1,149 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $293 | $15 |
2015: 21 services
| Return visit (30+ min) | 155 | $20,928 | $95 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 41 | $20,234 | $413 |
| Replacement of aortic valve through the skin and femoral artery | 26 | $19,344 | $744 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 27 | $15,444 | $552 |
| Long return visit (40+ min) | 71 | $11,948 | $139 |
| New patient visit (60+ min) | 61 | $11,923 | $195 |
| Critical care, first 30-74 minutes | 49 | $11,144 | $203 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 59 | $9,346 | $148 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 13 | $7,836 | $603 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $7,252 | $604 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $6,448 | $202 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 260 | $4,122 | $16 |
| Transitional care management services for problem of high complexity | 16 | $3,917 | $230 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 34 | $3,043 | $87 |
| New patient visit (45+ min) | 15 | $2,401 | $160 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $2,302 | $85 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 19 | $1,656 | $87 |
| External ekg recording for more than 48 hours up to 21 days | 36 | $1,054 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 33 | $846 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $178 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $129 | $8 |
2014: 21 services
| Return visit (30+ min) | 154 | $23,438 | $88 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 35 | $17,881 | $397 |
| Long return visit (40+ min) | 86 | $16,025 | $129 |
| New patient visit (60+ min) | 51 | $8,842 | $173 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 16 | $8,825 | $519 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 36 | $8,572 | $238 |
| Critical care, first 30-74 minutes | 35 | $7,666 | $192 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $7,027 | $213 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,837 | $570 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 12 | $6,116 | $437 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 34 | $5,394 | $150 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 296 | $4,651 | $15 |
| Transitional care management services for problem of high complexity | 17 | $3,912 | $217 |
| New patient visit (45+ min) | 19 | $2,600 | $137 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 25 | $2,297 | $79 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $2,220 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,967 | $179 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 22 | $1,907 | $79 |
| Transitional care management services for problem of at least moderate complexity | 11 | $1,700 | $155 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 57 | $515 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $156 | $13 |
2013: 19 services
| Return visit (30+ min) | 134 | $24,061 | $91 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $18,604 | $443 |
| Long return visit (40+ min) | 96 | $16,457 | $131 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 13 | $7,247 | $483 |
| Critical care, first 30-74 minutes | 31 | $7,229 | $190 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $5,270 | $203 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 28 | $4,202 | $140 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,869 | $298 |
| New patient visit (60+ min) | 22 | $3,827 | $174 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,738 | $170 |
| New patient visit (45+ min) | 18 | $2,437 | $135 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 27 | $2,318 | $77 |
| Short return visit (20+ min) | 26 | $1,843 | $54 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $1,622 | $85 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,390 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,257 | $90 |
| Hospital observation care on day of discharge | 15 | $958 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 51 | $834 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 46 | $449 | $7 |
Drugs they prescribed that Part D paid
$26,612
Pharmacies billed $26,612 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 133) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
106 generic and fewer than 11 brand-name prescriptions · $26,612 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 12 | $12,498 | $1,041 |
| Nitroglycerin Patch | 11 | $269 | $24 |
| Memantine | 11 | $220 | $20 |
| Levothyroxine | 12 | $164 | $14 |
| Clopidogrel | 15 | $77 | $5 |
Year by year
| 2024 | 133 | 35 | 0% (0) | None | $26,612 |
| 2023 | 118 | 40 | 0% (0) | None | $27,071 |
| 2022 | 120 | 45 | 0% (0) | None | $22,609 |
| 2021 | 150 | 51 | 0% (0) | 20% | $20,962 |
| 2020 | 163 | 59 | 0% (0) | 37% | $29,889 |
| 2019 | 219 | 67 | 0% (0) | 16% | $19,038 |
| 2018 | 426 | 100 | 0% (0) | 7% | $25,620 |
| 2017 | 751 | 194 | None | 8% | $42,981 |
| 2016 | 1,122 | 207 | 0% (0) | 13% | $60,162 |
| 2015 | 1,761 | 227 | 0% (0) | 14% | $82,377 |
| 2014 | 1,555 | 206 | 0% (0) | 18% | $74,209 |
| 2013 | 1,210 | 153 | None | 25% | $60,100 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Eliquis | 30 | $25,418 | $847 |
| Potassium Chloride | 12 | $155 | $13 |
| Furosemide | 23 | $119 | $5 |
2022: 3 drugs
| Eliquis | 19 | $13,740 | $723 |
| Clopidogrel | 17 | $386 | $23 |
| Furosemide | 22 | $125 | $6 |
2021: 6 drugs
| Eliquis | 19 | $16,752 | $882 |
| Clopidogrel | 14 | $431 | $31 |
| Isosorbide Mononitrate | 11 | $323 | $29 |
| Potassium Chloride | 18 | $237 | $13 |
| Atorvastatin | 11 | $139 | $13 |
| Lisinopril | 16 | $91 | $6 |
2020: 6 drugs
| Eliquis | 37 | $24,953 | $674 |
| Metoprolol | 13 | $438 | $34 |
| Clopidogrel | 16 | $307 | $19 |
| Isosorbide Mononitrate | 15 | $180 | $12 |
| Potassium Chloride | 11 | $149 | $14 |
| Furosemide | 13 | $71 | $5 |
2019: 8 drugs
| Eliquis | 15 | $12,760 | $851 |
| Clopidogrel | 31 | $834 | $27 |
| Atorvastatin | 17 | $436 | $26 |
| Metoprolol | 21 | $389 | $19 |
| Pantoprazole | 13 | $234 | $18 |
| Potassium Chloride | 16 | $183 | $11 |
| Furosemide | 12 | $51 | $4 |
| Amoxicillin | 12 | $25 | $2 |
2018: 11 drugs
| Eliquis | 16 | $11,959 | $747 |
| Atorvastatin | 102 | $2,464 | $24 |
| Isosorbide Mononitrate Er | 19 | $1,282 | $67 |
| Clopidogrel | 67 | $1,141 | $17 |
| Metoprolol | 26 | $1,063 | $41 |
| Pantoprazole | 22 | $521 | $24 |
| Losartan | 16 | $425 | $27 |
| Potassium Chloride | 12 | $199 | $17 |
| Amlodipine Besylate | 14 | $165 | $12 |
| Lisinopril | 14 | $148 | $11 |
| Metoprolol | 15 | $108 | $7 |
2017: 17 drugs
| Eliquis | 25 | $14,966 | $599 |
| Isosorbide Mononitrate Er | 58 | $2,994 | $52 |
| Atorvastatin | 113 | $2,909 | $26 |
| Metoprolol | 47 | $1,817 | $39 |
| Clopidogrel | 99 | $1,698 | $17 |
| Potassium Chloride | 27 | $449 | $17 |
| Losartan | 23 | $381 | $17 |
| Lisinopril | 31 | $326 | $11 |
| Pantoprazole | 12 | $311 | $26 |
| Metoprolol | 34 | $298 | $9 |
| Hydrochlorothiazide | 30 | $282 | $9 |
| Carvedilol | 28 | $231 | $8 |
| Amlodipine Besylate | 32 | $201 | $6 |
| Simvastatin | 14 | $157 | $11 |
| Atenolol | 14 | $122 | $9 |
| Furosemide | 11 | $84 | $8 |
| Amoxicillin | 24 | $70 | $3 |
2016: 21 drugs
| Eliquis | 40 | $16,056 | $401 |
| Atorvastatin | 185 | $3,672 | $20 |
| Metoprolol | 59 | $2,824 | $48 |
| Clopidogrel | 125 | $2,550 | $20 |
| Isosorbide Mononitrate Er | 54 | $2,215 | $41 |
| Amiodarone | 22 | $1,168 | $53 |
| Amlodipine Besylate | 74 | $727 | $10 |
| Pantoprazole | 29 | $536 | $18 |
| Potassium Chloride | 17 | $503 | $30 |
| Losartan | 37 | $439 | $12 |
| Pravastatin | 14 | $417 | $30 |
| Lisinopril | 43 | $412 | $10 |
| Metoprolol | 62 | $407 | $7 |
| Carvedilol | 27 | $340 | $13 |
| Nitrostat | 13 | $303 | $23 |
| Spironolactone | 19 | $279 | $15 |
| Atenolol | 29 | $236 | $8 |
| Hydrochlorothiazide | 42 | $215 | $5 |
| Omeprazole | 16 | $153 | $10 |
| Furosemide | 27 | $149 | $6 |
| Simvastatin | 17 | $144 | $8 |
2015: 30 drugs
| Crestor | 24 | $12,457 | $519 |
| Effient | 16 | $7,891 | $493 |
| Pradaxa | 11 | $6,303 | $573 |
| Eliquis | 19 | $6,208 | $327 |
| Atorvastatin | 317 | $5,921 | $19 |
| Metoprolol | 99 | $3,922 | $40 |
| Clopidogrel | 153 | $2,870 | $19 |
| Isosorbide Mononitrate Er | 77 | $1,617 | $21 |
| Diltiazem 24hr Er | 14 | $1,422 | $102 |
| Potassium Chloride | 45 | $932 | $21 |
| Carvedilol | 80 | $870 | $11 |
| Amiodarone | 39 | $858 | $22 |
| Cilostazol | 18 | $761 | $42 |
| Amlodipine Besylate | 107 | $738 | $7 |
| Pravastatin | 22 | $687 | $31 |
| Lisinopril | 83 | $669 | $8 |
| Losartan | 44 | $613 | $14 |
| Metoprolol | 85 | $500 | $6 |
| Hydrochlorothiazide | 43 | $497 | $12 |
| Pantoprazole | 24 | $462 | $19 |
| Hydralazine | 17 | $459 | $27 |
| Labetalol | 13 | $415 | $32 |
| Furosemide | 76 | $363 | $5 |
| Simvastatin | 22 | $274 | $12 |
| Warfarin | 24 | $273 | $11 |
| Nitrostat | 17 | $258 | $15 |
| Spironolactone | 25 | $258 | $10 |
| Omeprazole | 24 | $234 | $10 |
| Atenolol | 30 | $135 | $4 |
| Losartan-Hydrochlorothiazide | 14 | $101 | $7 |
2014: 25 drugs
| Crestor | 25 | $9,873 | $395 |
| Pradaxa | 12 | $8,174 | $681 |
| Ranexa | 11 | $7,593 | $690 |
| Atorvastatin | 268 | $6,320 | $24 |
| Clopidogrel | 130 | $4,839 | $37 |
| Metoprolol | 112 | $4,486 | $40 |
| Diltiazem 24hr Er | 30 | $2,051 | $68 |
| Isosorbide Mononitrate Er | 66 | $1,440 | $22 |
| Amlodipine Besylate | 116 | $1,032 | $9 |
| Carvedilol | 72 | $987 | $14 |
| Losartan | 49 | $881 | $18 |
| Lisinopril | 76 | $698 | $9 |
| Potassium Chloride | 29 | $642 | $22 |
| Metoprolol | 56 | $458 | $8 |
| Pantoprazole | 27 | $458 | $17 |
| Hydrochlorothiazide | 46 | $449 | $10 |
| Warfarin | 30 | $377 | $13 |
| Cartia Xt | 11 | $327 | $30 |
| Furosemide | 72 | $294 | $4 |
| Spironolactone | 24 | $250 | $10 |
| Omeprazole | 16 | $230 | $14 |
| Atenolol | 45 | $214 | $5 |
| Nitrostat | 17 | $198 | $12 |
| Simvastatin | 13 | $169 | $13 |
| Amiodarone | 16 | $162 | $10 |
2013: 28 drugs
| Crestor | 33 | $10,576 | $320 |
| Clopidogrel | 96 | $5,478 | $57 |
| Effient | 17 | $5,239 | $308 |
| Atorvastatin | 172 | $5,235 | $30 |
| Metoprolol | 91 | $3,763 | $41 |
| Diovan | 12 | $3,301 | $275 |
| Isosorbide Mononitrate Er | 73 | $1,501 | $21 |
| Losartan | 31 | $906 | $29 |
| Potassium Chloride | 27 | $852 | $32 |
| Carvedilol | 45 | $559 | $12 |
| Amlodipine Besylate | 54 | $497 | $9 |
| Pravastatin | 13 | $476 | $37 |
| Cartia Xt | 18 | $445 | $25 |
| Ramipril | 11 | $412 | $37 |
| Metoprolol | 45 | $382 | $8 |
| Diltiazem 24hr Er | 15 | $354 | $24 |
| Lisinopril | 47 | $354 | $8 |
| Furosemide | 68 | $351 | $5 |
| Nitrostat | 21 | $323 | $15 |
| Pantoprazole | 13 | $276 | $21 |
| Warfarin | 24 | $267 | $11 |
| Amiodarone | 16 | $256 | $16 |
| Omeprazole | 11 | $256 | $23 |
| Hydrochlorothiazide | 30 | $252 | $8 |
| Atenolol | 34 | $237 | $7 |
| Diltiazem Er | 11 | $213 | $19 |
| Disopyramide Phosphate | 13 | $200 | $15 |
| Simvastatin | 17 | $179 | $11 |
Money from drug and device companies
$25,182 in 2025
| 2025 | 6 | 32 | $23,508 | $25,182 |
| 2024 | 6 | 54 | $28,504 | $33,714 |
| 2023 | 5 | 11 | None | $714 |
| 2022 | 5 | 74 | $41,258 | $49,882 |
| 2021 | 5 | 121 | $45,185 | $78,317 |
| 2020 | 9 | 91 | $30,178 | $47,402 |
| 2019 | 16 | 164 | $62,284 | $83,470 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teleflex | Arrow | $18,958 | 4 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $5,902 | 21 payments
|
| Medtronic | Corevalve Evolut R | $178 | 2 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $120 | 3 payments
|
| Philips North America | Coronary Other | $17 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $6 | 1 payment
|
See all 32 published payments
| Medtronic | Meals · 2025-12-19 | Corevalve Evolut R | $154 |
| Edwards Lifesciences | Meals · 2025-12-11 | Pascal | $8 |
| Edwards Lifesciences | Meals · 2025-12-10 | None | $86 |
| Medtronic | Meals · 2025-12-03 | Symplicity G3 | $24 |
| Edwards Lifesciences | Meals · 2025-11-06 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $31 |
| Edwards Lifesciences | Meals · 2025-10-29 | Sapien 3 Ultra Resilia | $5 |
| Edwards Lifesciences | Meals · 2025-10-29 | Sapien 3 Ultra Resilia | $48 |
| Edwards Lifesciences | Meals · 2025-10-27 | None | $64 |
| Edwards Lifesciences | Meals · 2025-10-27 | Sapien 3 Ultra Resilia | $130 |
| Edwards Lifesciences | Meals · 2025-10-27 | None | $115 |
| Edwards Lifesciences | Meals · 2025-10-24 | Pascal | $185 |
| Teleflex | Royalties · 2025-10-17 | Arrow | $4,817 |
| Edwards Lifesciences | Meals · 2025-10-10 | Sapien 3 Ultra Resilia | $28 |
| Philips North America | Meals · 2025-09-18 | Coronary Other | $17 |
| Shockwave Medical | Meals · 2025-08-21 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $38 |
| Teleflex | Royalties · 2025-07-25 | Arrow | $4,498 |
| Edwards Lifesciences | Meals · 2025-07-17 | Pascal | $32 |
| Edwards Lifesciences | Meals · 2025-07-11 | Sapien 3 Ultra Resilia | $27 |
| Edwards Lifesciences | Meals · 2025-06-11 | Sapien 3 Ultra Resilia | $32 |
| Edwards Lifesciences | Meals · 2025-06-06 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $2 |
| Edwards Lifesciences | Meals · 2025-06-05 | None | $292 |
| Edwards Lifesciences | Consulting · 2025-04-28 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $4,550 |
| Teleflex | Royalties · 2025-04-25 | Arrow | $4,859 |
| Shockwave Medical | Meals · 2025-04-24 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $42 |
| Edwards Lifesciences | Meals · 2025-04-14 | Sapien 3 Ultra Resilia | $12 |
| Edwards Lifesciences | Meals · 2025-04-11 | Sapien 3 Ultra Resilia | $24 |
| Edwards Lifesciences | Meals · 2025-04-08 | Pascal | $149 |
| Edwards Lifesciences | Meals · 2025-04-04 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $50 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-18 | Lifevest | $6 |
| Shockwave Medical | Meals · 2025-03-18 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $41 |
| Edwards Lifesciences | Meals · 2025-03-13 | Pascal | $34 |
| Teleflex | Royalties · 2025-01-24 | Arrow | $4,785 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $33,714
| Teleflex | Arrow | $14,426 | 4 payments
|
| Medtronic | Corevalve Evolut R | $9,876 | 16 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $9,265 | 30 payments
|
| Seigla Medical | None | $86 | 1 payment
|
| Philips North America | (9266) Elca | $40 | 2 payments
|
| Boston Scientific | None | $22 | 1 payment
|
2023: $714
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $421 | 7 payments
|
| Acist Medical Systems | Hd-Ivus | $150 | 1 payment
|
| Medtronic | None | $104 | 1 payment
|
| Merit Medical Systems | None | $23 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $16 | 1 payment
|
2022: $49,882
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $49,566 | 69 payments
|
| Abbott Laboratories | Xience Sierra | $133 | 1 payment
|
| Abiomed | Impella | $127 | 2 payments
|
| Terumo Medical | Tr Band | $32 | 1 payment
|
| Medtronic | None | $24 | 1 payment
|
2021: $78,317
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $55,743 | 88 payments
|
| JenaValve Technology | Jenavalve Pericardial Tavr System | $20,183 | 5 payments
|
| Medtronic | Corevalve Evolut | $2,167 | 12 payments
|
| Philips Electronics North America | (6585) Omniwire | $138 | 2 payments
|
| Shockwave Medical | Vascular Lithotripsy | $87 | 5 payments
|
2020: $47,402
| Teleflex | Catheter - Guideliner | $22,530 | 26 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $12,444 | 40 payments
|
| Abbott Laboratories | Xience V Coronary Stent System | $7,048 | 12 payments
|
| Vascular Solutions | Guidewires | $3,000 | 1 payment
|
| JenaValve Technology | Jenavalve Pericardial Tavr System | $1,535 | 2 payments
|
| Medtronic Vascular | Corevalve Evolut | $750 | 1 payment
|
| Teleflex Medical Canada | None | $48 | 1 payment
|
| Boston Scientific | General - Structural Heart | $29 | 1 payment
|
| Acist Medical Systems | Cvi Systems | $17 | 1 payment
|
2019: $83,470
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $58,388 | 114 payments
|
| Vascular Solutions | Guidewires | $12,153 | 5 payments
|
| Abbott Laboratories | Xience V Coronary Stent System | $7,577 | 4 payments
|
| Teleflex | Interventional Products | $3,372 | 12 payments
|
| Medtronic Vascular | Corevalve Evolut | $754 | 9 payments
|
| Boston Scientific | Rotablator | $669 | 9 payments
|
| Biotronik | None | $158 | 1 payment
|
| Abiomed | Impella | $150 | 1 payment
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $100 | 1 payment
|
| AngioDynamics | None | $45 | 1 payment
|
| Terumo Medical | Metacross | $21 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $20 | 1 payment
|
| Acist Medical Systems | Cvi Consumables | $19 | 2 payments
|
| Arrow International | Manta | $18 | 1 payment
|
| ShockWave Medical | Vascular Lithotripsy | $15 | 1 payment
|
| JenaValve Technology | Jenavalve Pericardial Tavr System | $12 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2021 | Their institution | $189,991 |
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2023 | Their institution | $146,849 |
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2020 | Their institution | $132,608 |
| Edwards Lifesciences Corporation · The Encircle Trial (#2018-19) · 2024 | Their institution | $129,475 |
| Edwards Lifesciences Corporation · The Encircle Trial (#2018-19) · 2022 | Their institution | $129,189 |
| Edwards Lifesciences Corporation · The Encircle Trial (#2018-19) · 2025 | Their institution | $112,782 |
| Edwards Lifesciences Corporation · Sm3 Trial 2017-03 · 2020 | Their institution | $108,671 |
| Edwards Lifesciences Corporation · The Encircle Trial (#2018-19) · 2023 | Their institution | $91,195 |
| Edwards Lifesciences Corporation · The Progress Trial – Continued Access 2021-01-Cap · 2025 | Their institution | $70,674 |
| Edwards Lifesciences Corporation · The Encircle Trial (#2018-19) · 2021 | Their institution | $59,682 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2021 | Their institution | $59,673 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2020 | Their institution | $58,139 |
| BOSTON SCIENTIFIC CORPORATION · Reprise IV · 2020 | Their institution | $56,294 |
| Edwards Lifesciences Corporation · Alliance 2021-05 · 2023 | Their institution | $55,199 |
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2025 | Their institution | $48,939 |
| Edwards Lifesciences Corporation · Alliance 2021-05 · 2024 | Their institution | $39,716 |
| Edwards Lifesciences Corporation · Sm3 Trial 2017-03 · 2021 | Their institution | $35,956 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2022 | Their institution | $31,775 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2023 | Their institution | $30,382 |
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2024 | Their institution | $29,446 |
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2022 | Their institution | $27,845 |
| Edwards Lifesciences Corporation · The Progress Trial 2021-01 · 2023 | Their institution | $27,272 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2024 | Their institution | $22,392 |
| Edwards Lifesciences Corporation · The Progress Trial – Continued Access 2021-01-Cap · 2024 | Their institution | $19,445 |
| Edwards Lifesciences Corporation · The Encircle Trial (#2018-19) · 2020 | Their institution | $18,950 |
| Edwards Lifesciences Corporation · Alliance 2021-05 · 2025 | Their institution | $15,743 |
| Edwards Lifesciences Corporation · Alliance Aviv 2021-05 · 2024 | Their institution | $14,850 |
| Edwards Lifesciences Corporation · The Progress Trial 2021-01 · 2024 | Their institution | $14,328 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2025 | Their institution | $13,834 |
| Edwards Lifesciences Corporation · The Progress Trial 2021-01 · 2022 | Their institution | $13,500 |
| Edwards Lifesciences Corporation · Alliance 2021-05 · 2022 | Their institution | $13,500 |
| Edwards Lifesciences Corporation · Early Feasibility Study of the Cardiaq Transcatheter Mitral Valve Implantation (Tmvi) System 2013-05c · 2020 | Their institution | $12,206 |
| Boston Scientific Corporation · Reprise IV · 2021 | Their institution | $10,272 |
| Edwards Lifesciences Corporation · Sm3 Trial 2017-03 · 2023 | Their institution | $9,493 |
| Edwards Lifesciences Corporation · Sm3 Trial 2017-03 · 2024 | Their institution | $7,695 |
| Edwards Lifesciences Corporation · Sm3 Trial 2017-03 · 2022 | Their institution | $7,028 |
| Edwards Lifesciences Corporation · The Progress Trial 2021-01 · 2025 | Their institution | $4,589 |
| Edwards Lifesciences Corporation · Sm3 Trial 2017-03 · 2025 | Their institution | $3,416 |
| Medtronic, Inc. · 2024 | Their institution | $950 |
| Edwards Lifesciences Corporation · Early-Tavr Trial 2016-07 · 2019 | Their institution | $239 |
Professional record
- NPI
- 1629121975
- Licence
- CA A96709California A96709: Current · expires 2027-10-31
- Trained
- Loyola University of Chicago, Stritch School of Medicine, 2005
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-01-19
- NPI last updated
- 2020-06-22
- NPI record certified
- 2020-06-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301